CD86 and Alzheimer disease: In conclusion, we found that the B cell proliferation, CD80, CD86, and CD40 expression, IgG and IL-10 secretion, and switched memory B cell subsets were defective in AD-HIES patients induced by TLR7 and/or TLR9 agonist.